The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care

Application process for the Gatra Awards 2026 closed.

The awardees will be announced in September 2026.

Applications for the next edition 2027 will be accepted between 01/11/2026 and 31/05/2027.

To see the 2025 GATRA Award winner please click here.